Cardiogen — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Cardiogen

Also known as: Cardiogen peptide, T-32 (related peptide mentioned in same study)

Short bioregulatory peptide

Research chemicalLast updated: November 4, 2026Based on 1 peer-reviewed studyPreclinical data only — no human trials

What it is

Cardiogen is a short peptide studied in laboratory settings for its effects on aging cells, particularly in prostate and cardiovascular tissue. Research is limited to cell cultures and early animal work, with very little published evidence. No FDA-approved use; considered an early-stage research compound.

The scientific side

Only one abstract in the reviewed literature directly mentions Cardiogen by name. PMID 20586252 reports that cardiogen (alongside peptides T-32 and T-38) was studied for its effect on the expression of signaling factors of fibroblast differentiation in human prostate gland cell cultures. In aging prostate fibroblast cultures, the peptide demonstrated the ability to enhance the expression of CXCL12, WEDC1, and ghrelin — markers whose synthesis was significantly reduced in senescent cultures. No mechanism of action in cardiac tissue, no receptor target, and no cardiac-specific pharmacology are described in any of the provided abstracts.

Class: Short bioregulatory peptide

Administration & storage

Cautions
No human pharmacokinetic or safety data for Cardiogen are present in the reviewed literature — clinical safety profile is entirely unknown.,No animal toxicology or dose-ranging studies for Cardiogen are described in any reviewed abstract.,The sole abstract mentioning Cardiogen describes only in vitro cell culture work; no administration route or dose for living subjects is reported.,Sterile technique is essential for any injectable peptide preparation to prevent contamination (general harm-reduction principle).

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification

WADA

Not stated in reviewed literature — requires manual verification

Health Canada

Not stated in reviewed literature — requires manual verification